Because this effect is entirely glucose-dependent, insulin secretion decreases as plasma glucose approaches normal levels, providing a significant safety advantage over traditional secretagogues
In some cases, switching to oral semaglutide, oral tirzepatide, or the Microdose GLP-1 Protocol (starting at $129/month) may resolve the issue while maintaining weight loss benefits
10.1002/jssc.201900814 117 MacDiarmidS
At the time of writing, retatrutide has not received marketing authorisation from the MHRA or the EMA, and therefore does not have an approved Summary of Product Characteristics (SmPC) or Patient Information Leaflet (PIL) in the UK
Two honest caveats remain
The user started at a dosage of 0.5 mg/week, increasing it gradually until reaching a maximum dose of 2.5 mg, which they sustained for the last 6 months of their cycle